Allen Izu

2.8k total citations
37 papers, 2.0k citations indexed

About

Allen Izu is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Allen Izu has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Allen Izu's work include Influenza Virus Research Studies (7 papers), Bacterial Infections and Vaccines (6 papers) and Respiratory viral infections research (6 papers). Allen Izu is often cited by papers focused on Influenza Virus Research Studies (7 papers), Bacterial Infections and Vaccines (6 papers) and Respiratory viral infections research (6 papers). Allen Izu collaborates with scholars based in United States, Italy and Switzerland. Allen Izu's co-authors include Howard S. Jaffe, Andria Langenberg, Lawrence Corey, Rose E. Sekulovich, Nicola Groth, Cornelia L. Dekker, Sandra J. Holmes, Adaora A. Adimora, Richard P. DiCarlo and John M. Douglas and has published in prestigious journals such as The Lancet, JAMA and Annals of Internal Medicine.

In The Last Decade

Allen Izu

37 papers receiving 1.8k citations

Peers

Countries citing papers authored by Allen Izu

Since Specialization

Citations

This map shows the geographic impact of Allen Izu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Izu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Izu more than expected).

Fields of papers citing papers by Allen Izu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen Izu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Izu. The network helps show where Allen Izu may publish in the future.

Co-authorship network of co-authors of Allen Izu

This figure shows the co-authorship network connecting the top 25 collaborators of Allen Izu. A scholar is included among the top collaborators of Allen Izu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen Izu. Allen Izu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Five year follow-up after primary vaccination against tick-borne encephalitis in children	Vaccine	Allen Izu, Dieter Gniel et al.	12
2	Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants	Vaccine	Arturo Abdelnour, Nan‐Chang Chiu et al.	16
3	Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents	The Journal of Pediatrics	Roger Baxter, Keith S. Reisinger et al.	33
4	Antibody Persistence and Response to a Booster Dose of a Quadrivalent Conjugate Vaccine for Meningococcal Disease in Adolescents	The Pediatric Infectious Disease Journal	Robert M. Jacobson, Lisa A. Jackson et al.	33
5	Comments on ‘Sample size for equivalence trials: a case study from a vaccine lot consistency trial’	Statistics in Medicine	Jitendra Ganju, Allen Izu	1
6	Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons	Human Vaccines & Immunotherapeutics	Maria Lattanzi, Allen Izu et al.	10
7	Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults	Clinical Infectious Diseases	Sharon E. Frey, Timo Vesikari et al.	117
8	Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity	The Journal of Infectious Diseases	Keith S. Reisinger, S. Block et al.	55
9	Sample size for equivalence trials: A case study from a vaccine lot consistency trial	Statistics in Medicine	Jitendra Ganju, Allen Izu et al.	3
10	Effectiveness of Sodium Hypochlorite in Preventing Inoculation of Periapical Tissues With Contaminated Patency Files	Journal of Endodontics	Sunil Thomas, Ping Zhang et al.	36
11	An acellular pertussis vaccine in healthy adults: safety and immunogenicity	Vaccine	Edward Rothstein, Edwin L. Anderson et al.	22
12	Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine	The Journal of Infectious Diseases	Sharon E. Frey, Christopher Harrison et al.	86
13	Safety and immunogenicity of Chiron/Biocine® recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers	The Pediatric Infectious Disease Journal	Steven Black, Henry R. Shinefield et al.	18
14	Safety, Pharmacokinetics, and Antiviral Response of CD4-Immunoglobulin G by Intravenous Bolus in AIDS and AIDS-Related Complex	Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology	Ann C. Collier, Robert W. Coombs et al.	6
15	Treatment of steroid‐dependent asthma with recombinant interferon‐gamma	Clinical & Experimental Allergy	Mark Boguniewicz, Lynda C. Schneider et al.	40
16	Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine	The Lancet	David H. Schwartz, Geoffrey J. Gorse et al.	93
17	Recombinant interferon gamma therapy for atopic dermatitis	Journal of the American Academy of Dermatology	Jon M. Hanifin, Lynda C. Schneider et al.	216
18	A randomized prospective clinical trial to determine the efficacy of interferon-γ in severely injured patients	The American Journal of Surgery	Hiram C. Polk, William G. Cheadle et al.	143
19	Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels	The American Journal of Medicine	Howard S. Jaffe, Allen Izu et al.	124
20	Effect of Dose and Immunization Schedule on Immune Response of Baboons to Recombinant Glycoprotein 120 of HIV-1	The Journal of Infectious Diseases	Cathy H. Lucas, Carl V. Hanson et al.	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact